Blockchain Registration Transaction Record

Creative Biolabs Unveils Next-Gen Vesicular Systems for Breakthrough Drug Delivery

Creative Biolabs expands lipid-based delivery services with Ethosomes, Transfersomes & Transethosomes for enhanced skin penetration in pharmaceutical & cosmetic applications.

This development represents a significant advancement in non-invasive medicine that could transform treatment approaches across multiple therapeutic areas. For patients, these technologies mean potentially replacing painful injections with topical applications for conditions ranging from chronic pain to autoimmune disorders, while improving drug efficacy through enhanced skin penetration. The cosmetic industry benefits from more effective delivery of anti-aging compounds and therapeutic ingredients. Researchers gain powerful new tools for drug development, particularly for sensitive molecules like peptides and proteins that previously required invasive administration. As healthcare continues shifting toward patient-friendly delivery methods, these vesicular systems address critical barriers in transdermal medicine, potentially accelerating development of new treatments while improving patient compliance and quality of life.